Lumir Mission Study

The Lumir Mission Research Portfolio objective is to bring medicinal cannabis knowledge and medicines from the darkness into the light. The Lumir Mission represents a significant investment in research across Australia, the United States, and United Kingdom, in partnership with leading academic institutions. With nine studies in the pipeline, three of which are active in Australia, The Lumir Mission Research Portfolio will contribute significantly to the cannabis evidence base over the coming decade. Join a Lumir Mission Study today! 🌿 The Lumir Mission Primary Dysmenorrhea (Period Pain) Study: an observational study which follows 65 women aged 20+ as they utilise medicinal cannabis to assess whether it is effective in managing their period pain, in a real-world setting, as prescribed by a Lumir Mission doctor. 🌿 The Lumir Mission Menopause and Sleep Disturbance Study: an observational study which follows 60 women aged 45-65 as they utilise medicinal cannabis to assess whether it is effective in improving sleep quality (getting to sleep and staying asleep) and other symptoms of menopause, in a real world setting, as prescribed by a Lumir Mission doctor. 🌿 The Lumir Mission Study: our flagship study is condition agnostic and open to anyone living in Australia, aged 18+ who is prescribed medicinal cannabis. This web-delivered survey-based study collects data monthly over four years to inform product innovation and prescribing guidelines to give health professionals 'big-data confidence' when working with patients. Register now at www.lumirmission.com, or contact hello@lumirmission.com for more information.